Lovastatin Tablet
Product Images NDC 71335-0045

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lovastatin (NDC 71335-0045). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl713350045)

Lovastatin 40 mg tablet label by Bryant Ranch Prepack, compared to Mevacor 40 mg tablet by Carlsbad Technology Inc. The label specifies oral route, a package count of 30 tablets, and storage instructions at 20-25°C (68-77°F). It includes warnings to keep out of reach of children and features a barcode and NDC 71335-0045.*

FDA Label Image

Structural Formula (Lov00 0004 01)

Chemical structure of Lovastatin is depicted in the image. The diagram shows the molecular arrangement of atoms with bonds indicating the stereochemistry and functional groups typical of Lovastatin.*

FDA Label Image

Table I (Lov00 0004 02)

Table presenting the effect of other drugs on Lovastatin exposure when co-administered. It includes the number of subjects, dosing of coadministered drugs or grapefruit juice, dosing of Lovastatin, and AUC ratios comparing exposure with and without the coadministered drug.*

FDA Label Image

Figure 1 (Lov00 0004 03)

A line graph titled 'Acute Major Coronary Events (Primary Endpoint)' showing the proportion of participants without event over years of follow-up. The graph compares Lovastatin and placebo groups with Lovastatin showing a higher event-free proportion and a 37% risk reduction indicated.*

FDA Label Image

Table Vii (Lov00 0005 04)

A data table titled 'Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis' listing interacting agents such as strong CYP3A4 inhibitors, HIV protease inhibitors, gemfibrozil, cyclosporine, danazol, diltiazem, dronedarone, verapamil, amiodarone, and grapefruit juice, along with prescribing recommendations for use with lovastatin, including contraindications or dosage limits.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.